Species differences in bile acid synthesis
Species differences in bile acid synthesis. (A) The classic bile acid synthesis pathway: cholesterol 7α-hydroxylase (CYP7A1) converts cholesterol to 7α-hydroxycholesterol (7α-HOC). The sterol 12α-hydroxylase (CYP8B1) converts the intermediate 7α-hydroxy-4 cholesten-3-one (C4) to 7α, 12α-dihydroxy-4-cholesten-3-one, eventually leading to synthesis of cholic acid (CA). C4 can also be eventually converted to chenodeoxycholic acid (CDCA). The mitochondrial sterol 27-hydroxylase (CYP27A1) catalyses the steroid side-chain oxidation of CA and CDCA. The alternative bile acid synthesis pathway: CYP27A1 converts cholesterol to 27-hydroxycholesterol (27-HOC), which mainly leads to the synthesis of CDCA. In mouse liver, CYP2C70 converts CDCA to α-MCA, which can be epimerized to β-MCA. In small and large intestine, bacterial bile salt hydrolase (BSH) deconjugates bile acids. Bacterial 7-dehydroxylase dehydroxylates CA to produce deoxycholic acid (DCA) and CDCA to produce lithocholic acid (LCA). Bacterial enzymes also produce secondary bile acids, including ω-muricholic acid (ω-MCA) and ursodeoxycholic acid (UDCA). (B–D) Structure of primary and secondary bile acids
Publication
Bile acids regulation of cellular stress responses in liver physiology and diseases (2024) Tiangang Li, et al. eGastroenterology. 2024 Jun 7;2(2). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CYP7A1 | CYP7A1 | ncbigene_symbol | CYP7A1 | 1581 |
| Homo sapiens | Primates | CYP8B1 | CYP8B1 | ncbigene_symbol | CYP8B1 | 1582 |
| Homo sapiens | Primates | CYP27A1 | CYP27A1 | ncbigene_symbol | CYP27A1 | 1593 |
| Homo sapiens | Primates | LCA | LCA | ncbigene_synonym | CLTA | 1211 |
| Homo sapiens | Primates | LCA | LCA | ncbigene_synonym | GUCY2D | 3000 |
| Homo sapiens | Primates | LCA | LCA | ncbigene_synonym | PTPRC | 5788 |
| Homo sapiens | Primates | DCA | DCA | ncbigene_synonym | HLA-DQA2 | 3118 |
| Homo sapiens | Primates | CDCA1 | CDCA1 | ncbigene_synonym | NUF2 | 83540 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Cholesterol | cholesterol | cholesterol | chebi:16113 | |
| CDCA | CDCA | 3alpha,7alpha-dihydroxy-5beta-cholan-24-oic acid | chebi:16755 | |
| glycine | glycine | 2-azaniumylacetate | chebi:57305 | |
| taurine | taurine | taurine | chebi:507393 | |
| CDCA | CDCA | 3alpha,7alpha-dihydroxy-5beta-cholan-24-oic acid | chebi:16755 | |
| glycine | glycine | 2-azaniumylacetate | chebi:57305 | |
| taurine | taurine | taurine | chebi:507393 | |
| glycine | glycine | 2-azaniumylacetate | chebi:57305 | |
| taurine | taurine | taurine | chebi:507393 | |
| glycine | glycine | 2-azaniumylacetate | chebi:57305 | |
| taurine | taurine | taurine | chebi:507393 | |
| BSH | BSH | (2S)-2-{[2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranosyl]oxy}butanedioic acid | chebi:61338 | |
| BSH | BSH | (2S)-2-{[2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranosyl]oxy}butanedioic acid | chebi:61338 | |
| BSH | BSH | (2S)-2-{[2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranosyl]oxy}butanedioic acid | chebi:61338 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|